![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Y Wang and GM Fuller
Department of Cell Biology, University of Alabama at Birmingham 35294.
Recent evidence has shown that members of the Jak kinase family are activated after IL-6 binds to its receptor complex, leading to a tyrosine phosphorylation of gp130, the IL-6 signal-transducing subunit. The different members of the IL-6 cytokine subfamily induce distinct patterns of Jak-Tyk phosphorylation in different cell types. Using monospecific antibodies to gp130, Jak2 kinase, and phosphotyrosine, we investigated the kinetics of IL-6 stimulation of members of this pathway in primary hepatocytes. Our findings show that Jak 2 is maximally activated within 2 min of exposure to IL-6, followed by gp130 phosphorylation that reaches its peak in another 2 min then declines to basal level by 60 min. In vitro phosphorylation experiments show that activated Jak 2 is able to phosphorylate both native gp130 and a fusion peptide containing its cytoplasmic domain, demonstrating gp130 is a direct substrate of Jak 2 kinase. Experiments designed to explore the cell surface expression of gp130 show that > or = 2 h are required to get a second round of phosphorylation after the addition of more cytokines. This finding suggests that activated gp130 is internalized from the cell surface after IL-6 stimulation. Additional experiments using protein synthesis inhibitors reveal that new protein synthesis is required to get a second cycle of gp130 phosphorylation indicating gp130 must be synthesized de novo and inserted into the membrane. These findings provide strong evidence that down regulation of the IL-6 signal in hepatocytes involves the internalization and cytosol degradation of gp130.
This article has been cited by other articles:
|
|
 |
|
  J. D. French, D. K. Walters, and D. F. Jelinek Transactivation of gp130 in Myeloma Cells J. Immunol., April 1, 2003; 170(7): 3717 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. O'Brien and S. C. Manolagas Isolation and Characterization of the Human gp130 Promoter. REGULATION BY STATS J. Biol. Chem., June 6, 1997; 272(23): 15003 - 15010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Y. Wu and R. A. Bradshaw Induction of Neurite Outgrowth by Interleukin-6 Is Accompanied by Activation of Stat3 Signaling Pathway in a Variant PC12 Cell (E2) Line J. Biol. Chem., May 31, 1996; 271(22): 13023 - 13032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Watanabe, T. Itoh, and K.-i. Arai JAK2 Is Essential for Activation of c-fos and c-myc Promoters and Cell Proliferation through the Human Granulocyte-Macrophage Colony-stimulating Factor Receptor in BA/F3 Cells J. Biol. Chem., May 24, 1996; 271(21): 12681 - 12686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Fuhrer, G.-S. Feng, and Y.-C. Yang Syp Associates with gp130 and Janus Kinase 2 in Response to Interleukin-11 in 3T3-L1 Mouse Preadipocytes J. Biol. Chem., October 20, 1995; 270(42): 24826 - 24830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu and Z. Liu Detection of a Novel Transcription Factor for the Aalpha Fibrinogen Gene in Response to Interleukin-6 J. Biol. Chem., March 31, 1995; 270(13): 7580 - 7586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Gibson, W. P. Schiemann, L. B. Prichard, J. M. Reno, L. H. Ericsson, and N. M. Nathanson Phosphorylation of Human gp130 at Ser-782 Adjacent to the Di-leucine Internalization Motif. EFFECTS ON EXPRESSION AND SIGNALING J. Biol. Chem., July 14, 2000; 275(29): 22574 - 22582. [Abstract] [Full Text] [PDF]
|
|
